Atossa Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Atossa Therapeutics has a total shareholder equity of $91.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $96.3M and $5.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$88.46m |
Equity | US$91.02m |
Total liabilities | US$5.24m |
Total assets | US$96.25m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ATOS *'s short term assets ($92.2M) exceed its short term liabilities ($5.2M).
Long Term Liabilities: ATOS * has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ATOS * is debt free.
Reducing Debt: ATOS * has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATOS * has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ATOS * has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.